Hot Life Science Investor Mandate 2: Large Pharma Company Seeking Partnerships in Cardio, Oncology, Virology and More

27 Aug

A large pharmaceutical company with offices worldwide uses a wide variety of structures in order to engage with innovative early-stage companies, including in-licensing, equity investments, options, collaborations, and acquisitions. The firm is currently looking to form new partnerships with early stage companies worldwide.

The firm is interested in therapeutic assets in the following key disease areas: cardiovascular, fibrosis, immunology, oncology, virology, and genetically-defined diseases. The firm can invest at any stage of development, from very early discovery-stage assets through to marketed products. The firm is open to any technological approach, but is only interested in novel drugs; biosimilars and reformulations are not of interest.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: